# Novo Nordisk CEO Testifies on Ozempic & Wegovy Prices ### Key Points: – The CEO of Novo Nordisk, Lars Fruergaard Jørgensen, testified before the US Congress about the pricing of their weight loss medications, Ozempic and Wegovy. – Jørgensen defended the pricing of these medications, stating that they reflect the value they bring to patients in terms of weight loss and overall health improvement. – Congress members questioned the CEO about the affordability and accessibility of these medications for patients, especially those without insurance coverage. – Novo Nordisk’s focus on developing innovative treatments for weight management and diabetes was highlighted during the hearing. Novo Nordisk’s CEO’s testimony shed light on the importance of access to effective weight loss medications like Ozempic and Wegovy. The company’s commitment to providing innovative solutions for weight management and diabetes is commendable. It is essential for individuals looking to lose weight to have access to safe and effective medications, and Novo Nordisk plays a crucial role in this aspect. If you are considering weight loss medications, contact Mindful Evolution for personalized guidance and support. Weight Loss Disclaimer: Individual results may vary. Mindful Evolution offers telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact us today at 954-639-9960 or visit our website https://yourmindfulevolution.com.